Overview
PT Enseval Putera Megatrading Tbk, commonly known as Enseval, is one of Indonesia’s largest integrated distribution and logistics companies in the healthcare sector. Established in 1973 and publicly listed on the Indonesia Stock Exchange in 1994, the company plays a key role in distributing pharmaceuticals, consumer products, medical equipment, raw materials for the pharma and food industries, as well as veterinary products. Backed by over 70 branches across Indonesia and three major distribution hubs in Jakarta, Cikarang, and Surabaya, Enseval has built a strong nationwide network supported by warehouses, cold-chain facilities, and a dedicated delivery fleet.
Through its subsidiaries, the company has diversified into healthcare services (clinics under the Mitrasana brand, dialysis services), medical devices, raw materials, and digital platforms such as EMOS for B2B pharmaceutical transactions and Mostrans for health-focused logistics. Financially, Enseval continues to deliver steady growth, with revenues surpassing IDR 30 trillion in 2024 and net profits of around IDR 742 billion. Employing over 5,000 people, the company maintains a solid market position under the Kalbe Farma group, offering investors stability with a healthy dividend yield and consistent performance. Its combination of physical infrastructure, digital innovation, and extensive product portfolio makes Enseval a crucial backbone of Indonesia’s healthcare supply chain.
